By Rebecca Beyer
Daily Journal Staff Writer
This article appears on Page 1
SAN FRANCISCO - The first personal injury trial against drugmaker Pfizer over its painkiller Bextra was postponed indefinitely, leading an expert to speculate a settlement is looming.
Jury selection in the trial, involving claims that the drug caused the heart attack and death of a 66-year-old Utah man, w...
Daily Journal Staff Writer
This article appears on Page 1
SAN FRANCISCO - The first personal injury trial against drugmaker Pfizer over its painkiller Bextra was postponed indefinitely, leading an expert to speculate a settlement is looming.
Jury selection in the trial, involving claims that the drug caused the heart attack and death of a 66-year-old Utah man, w...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In